by Mybiogate | Dec 8, 2020 | China Market
by Mybiogate | Dec 3, 2020 | China Market
Author: MyBioGate December 1, 2020 is the 33rd “World AIDS Day” with the theme: “Ending the HIV/AIDS Epidemic: Resilience and Impact”. Today we will take a brief look current AIDS treatment drugs, the market, and the progress of research... by Mybiogate | Dec 3, 2020 | Chinese company profile
Simcere Pharmaceutical Group 2019 Revenue: US$ 767.4 million Number of Employees: 5,000+ Founded: 1995 Overview Simcere is a research and development driven Chinese pharmaceutical company committed to bringing high quality, effective therapies to patients by... by Mybiogate | Dec 1, 2020 | Industry Research
Author: HE Sheng Endocrine therapy is a first-line therapy for prostate cancer, with gonadotropin-releasing hormones (GnRH) occupying a strong position. Although the incidence of prostate cancer in China is much lower than that in the United States, with life... by Mybiogate | Nov 20, 2020 | Industry Research
Author: HE Sheng Migraine is a common neurological disease, which can be chronic. According to the Migraine Research Foundation, symptoms include a severe throbbing recurring pain, usually on one side of the head and at least one of the following: “visual...